Search Results - Marissa Herrman

265 ADI-925: an allogeneic off-the-shelf chimeric adapter (CAd) γδ T cell therapy targeting NKG2D ligand-expressing cancers by Xue Yang, Marissa Herrman, Jonathan Wong, Ramandeep Kaur, Taylor Barca, Kevin P Nishimoto, Maryam Tabrizizad, Arun Bhat, Blake T Aftab, Morgan Smith-Boeck, Louise Kiru, Kyle McSweeney, Amy Doan, Kimberly Rodriquez, Smitha Rao Yelaguli Gundurao, Ngoc T Hoang, Hayden Tessman, Taylor Wingfield, Philip A Storm, Christopher J Rold, Swapna Panuganti

ADI-270: an armored allogeneic gamma delta T cell therapy designed to target CD70-expressing solid and hematologic malignancies by Jie Zhang, Jyothi Sethuraman, Marissa Herrman, Pranav Murthy, Ramandeep Kaur, Jonathan T S Wong, Kevin P Nishimoto, Smitha R Y Gundurao, Arun Bhat, Blake T Aftab, Shon Green, Aruna Azameera, Morgan Smith-Boeck, Michael Salum, Yvan Chanthery, Melinda Au, Amy Doan, Christopher J Rold, Swapna Panuganti, Helen Budworth, Gauri Lamture, Alexander G Teague, Yogendra Verma, Elizabeth B Speltz, Katherine M Wang, Dishant Bhatwala, Ana Giner-Rubio, Pavan Puligujja, Aya Jakobovits

Get full text